Petra Nitschke, Biopharma Insights Contributor, Business Development CEVEC Pharmaceuticals GmbH

home / authors / petra-nitschke-biopharma-insights-contributor-business-development-cevec-pharmaceuticals-gmbh

Petra Nitschke is your initial point of contact for CEVEC. Before joining the company in 2019 she held various positions in Business Development, Marketing and Finance, both, in large multinational corporations, including Novartis, as well as in a Bio-Engineering startup.
email: bizdev@cevec.com

Articles

ELEVECTA® - The Next Level in Gene Therapy AAV Production

Petra Nitschke, Biopharma Insights Contributor, Business Development CEVEC Pharmaceuticals GmbH
August 10th 2020

Introduction of ELEVECTA®, CEVEC’s fully scalable and stable production platform for AAV gene therapy viral vector manufacturing.

Latest Updated Articles

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
Published: September 11th 2024 | Updated: September 18th 2024
CPHI Pharma Award Finalists Announced for 2024
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
Published: March 27th 2024 | Updated: June 28th 2024
AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product
Published: December 9th 2024 | Updated: December 22nd 2024
Recap Key Industry Trends for Viral Clearance and NGS
Shining Pro - Stock.Adobe.com
Published: December 7th 2024 | Updated: December 22nd 2024
Enhancing Quality Through Training
Published: July 20th 2020 | Updated: December 22nd 2024
Contact BioPharm International Editors
Published: July 19th 2020 | Updated: December 22nd 2024
Editorial Information: BioPharm International Submission Guidelines and Editorial Calendars
© 2024 MJH Life Sciences

All rights reserved.